Expression in ProstateCancerCells:TheRole of Bone Microenvironment-AssociatedCXCL12
暂无分享,去创建一个
[1] D. Taub,et al. Dynamic reorganization of chemokine receptors, cholesterol, lipid rafts, and adhesion molecules to sites of CD4 engagement. , 2005, Experimental cell research.
[2] Bonnie F. Sloane,et al. Matrix metalloproteinase activity and osteoclasts in experimental prostate cancer bone metastasis tissue. , 2005, The American journal of pathology.
[3] Shailesh Singh,et al. CXCL12–CXCR4 interactions modulate prostate cancer cell migration, metalloproteinase expression and invasion , 2004, Laboratory Investigation.
[4] Brian Barnett,et al. Bone Marrow Is a Reservoir for CD4+CD25+ Regulatory T Cells that Traffic through CXCL12/CXCR4 Signals , 2004, Cancer Research.
[5] M. Kruhøffer,et al. Functional expression of the CXCR4 chemokine receptor is induced by RET/PTC oncogenes and is a common event in human papillary thyroid carcinomas , 2004, Oncogene.
[6] N. Dolloff,et al. CX3CR1-Fractalkine Expression Regulates Cellular Mechanisms Involved in Adhesion, Migration, and Survival of Human Prostate Cancer Cells , 2004, Cancer Research.
[7] A. Mantovani,et al. Chemokines in neoplastic progression. , 2004, Seminars in cancer biology.
[8] Tae-Hee Lee,et al. Involvement of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1alpha in breast cancer cell migration through human brain microvascular endothelial cells. , 2004, Molecular cancer research : MCR.
[9] A. Poggi,et al. Migration of V delta 1 and V delta 2 T cells in response to CXCR3 and CXCR4 ligands in healthy donors and HIV-1-infected patients: competition by HIV-1 Tat. , 2004, Blood.
[10] Y. Rao,et al. Slit Protein-mediated Inhibition of CXCR4-induced Chemotactic and Chemoinvasive Signaling Pathways in Breast Cancer Cells* , 2004, Journal of Biological Chemistry.
[11] S. Saccani,et al. Regulation of the Chemokine Receptor CXCR4 by Hypoxia , 2003, The Journal of experimental medicine.
[12] H. Yoshida,et al. Possible role of stromal-cell-derived factor-1/CXCR4 signaling on lymph node metastasis of oral squamous cell carcinoma. , 2003, Experimental cell research.
[13] H. Moch,et al. Chemokine receptor CXCR4 downregulated by von Hippel–Lindau tumour suppressor pVHL , 2003, Nature.
[14] P. Collin‐Osdoby,et al. Stromal Cell‐Derived Factor‐1 (SDF‐1) Recruits Osteoclast Precursors by Inducing Chemotaxis, Matrix Metalloproteinase‐9 (MMP‐9) Activity, and Collagen Transmigration , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[15] A. Nagler,et al. HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34+ stem cell recruitment to the liver. , 2003, The Journal of clinical investigation.
[16] J. Benovic,et al. The ins and outs of G protein-coupled receptor trafficking. , 2003, Trends in biochemical sciences.
[17] Ed Roos,et al. The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases. , 2003, Cancer research.
[18] K. Pienta,et al. Expression of CXCR4 and CXCL12 (SDF‐1) in human prostate cancers (PCa) in vivo , 2003, Journal of cellular biochemistry.
[19] C. Cordon-Cardo,et al. A multigenic program mediating breast cancer metastasis to bone. , 2003, Cancer cell.
[20] R. Bonavia,et al. Stromal cell-derived factor 1alpha stimulates human glioblastoma cell growth through the activation of both extracellular signal-regulated kinases 1/2 and Akt. , 2003, Cancer research.
[21] R. Ganju,et al. Differential Regulation of CXCR4-mediated T-cell Chemotaxis and Mitogen-activated Protein Kinase Activation by the Membrane Tyrosine Phosphatase, CD45* , 2003, The Journal of Biological Chemistry.
[22] V. Wee Yong,et al. CXCR4 Is a Major Chemokine Receptor on Glioma Cells and Mediates Their Survival* , 2002, The Journal of Biological Chemistry.
[23] I. Fidler,et al. The organ microenvironment and cancer metastasis. , 2002, Differentiation; research in biological diversity.
[24] Gordon Stamp,et al. Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer. , 2002, Cancer research.
[25] Oana A. Tomescu,et al. CXCR4-SDF-1 signaling is active in rhabdomyosarcoma cells and regulates locomotion, chemotaxis, and adhesion. , 2002, Blood.
[26] I. Petit,et al. Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. , 2002, Experimental hematology.
[27] B. Hemmings,et al. Identification of a Plasma Membrane Raft-Associated PKB Ser473 Kinase Activity that Is Distinct from ILK and PDK1 , 2002, Current Biology.
[28] Giovanni Martinelli,et al. CXCR4 neutralization, a novel therapeutic approach for non-Hodgkin's lymphoma. , 2002, Cancer research.
[29] Nils Brünner,et al. Synthetic matrix metalloproteinase inhibitors inhibit growth of established breast cancer osteolytic lesions and prolong survival in mice. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[30] S. Rafii,et al. Recruitment of Stem and Progenitor Cells from the Bone Marrow Niche Requires MMP-9 Mediated Release of Kit-Ligand , 2002, Cell.
[31] H. Chap,et al. Phosphoinositide 3-kinases in lysophosphatidic acid signaling: regulation and cross-talk with the Ras/mitogen-activated protein kinase pathway. , 2002, Biochimica et biophysica acta.
[32] M. Freeman,et al. Cholesterol-rich lipid rafts mediate akt-regulated survival in prostate cancer cells. , 2002, Cancer research.
[33] Evan T Keller,et al. Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone. , 2002, Cancer research.
[34] R. Fridman,et al. Matrix metalloproteinase activity, bone matrix turnover, and tumor cell proliferation in prostate cancer bone metastasis. , 2002, Journal of the National Cancer Institute.
[35] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[36] C. Cohen,et al. Chemokine-Induced Secretion of Gelatinase B in Primary Human Monocytes , 2001, Biological chemistry.
[37] R. Fridman,et al. Differential regulation of matrix metalloproteinase‐9, tissue inhibitor of metalloproteinase‐1 (TIMP‐1) and TIMP‐2 expression in co‐cultures of prostate cancer and stromal cells , 2001, International journal of cancer.
[38] Sang-Oh Yoon,et al. Inhibitory Effect of Selenite on Invasion of HT1080 Tumor Cells* , 2001, The Journal of Biological Chemistry.
[39] M. Ittmann,et al. Secreted caveolin-1 stimulates cell survival/clonal growth and contributes to metastasis in androgen-insensitive prostate cancer. , 2001, Cancer research.
[40] T. Mcclanahan,et al. Involvement of chemokine receptors in breast cancer metastasis , 2001, Nature.
[41] Terry L. Smith,et al. Bone-targeted therapy for advanced androgen-independent carcinoma of the prostate: a randomised phase II trial , 2001, The Lancet.
[42] S. Rafii,et al. Stromal-derived factor 1-induced megakaryocyte migration and platelet production is dependent on matrix metalloproteinases. , 2000, Blood.
[43] M. Ratajczak,et al. Differential MMP and TIMP production by human marrow and peripheral blood CD34(+) cells in response to chemokines. , 2000, Experimental hematology.
[44] Kai Simons,et al. Lipid rafts and signal transduction , 2000, Nature Reviews Molecular Cell Biology.
[45] H. Moch,et al. Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. , 2000, Human pathology.
[46] M. Ratajczak,et al. Binding of stromal derived factor‐1α(SDF‐1α) to CXCR4 chemokine receptorin normal human megakaryoblasts butnot in platelets induces phosphorylationof mitogen‐activated protein kinase p42/44 (MAPK), ELK‐1 transcription factor and serine/threonine kinase AKT , 2000, European journal of haematology.
[47] K. Moelling,et al. Phosphorylation and regulation of Raf by Akt (protein kinase B). , 1999, Science.
[48] S. R. Datta,et al. Cellular survival: a play in three Akts. , 1999, Genes & development.
[49] W. Liu,et al. Up-regulation of Akt3 in Estrogen Receptor-deficient Breast Cancers and Androgen-independent Prostate Cancer Lines* , 1999, The Journal of Biological Chemistry.
[50] J. Westermarck,et al. Regulation of matrix metalloproteinase expression in tumor invasion , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[51] D. Grignon,et al. Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone. , 1999, Cancer research.
[52] S. Bagrodia,et al. Cytoskeletal Reorganization by G Protein-Coupled Receptors Is Dependent on Phosphoinositide 3-Kinase γ, a Rac Guanosine Exchange Factor, and Rac , 1998, Molecular and Cellular Biology.
[53] R. Doms,et al. CD4-Independent Infection by HIV-2 Is Mediated by Fusin/CXCR4 , 1996, Cell.
[54] E. Ruoslahti,et al. Integrins and tumor cell dissemination. , 1989, Cancer cells.
[55] S Paget,et al. THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST. , 1889 .
[56] M. Ratajczak,et al. Incorporation of CXCR4 into membrane lipid rafts primes homing-related responses of hematopoietic stem/progenitor cells to an SDF-1 gradient. , 2005, Blood.
[57] R. Alon,et al. Atypical PKC-zeta regulates SDF-1-mediated migration and development of human CD34+ progenitor cells. , 2005, The Journal of clinical investigation.
[58] Yiwei Li,et al. Selective growth regulatory and pro-apoptotic effects of DIM is mediated by AKT and NF-kappaB pathways in prostate cancer cells. , 2005, Frontiers in bioscience : a journal and virtual library.
[59] R. Fridman,et al. Matrix metalloproteinaes and bone metastasis. , 2004, Cancer treatment and research.
[60] A. Jemal,et al. Cancer Statistics, 2004 , 2004, CA: a cancer journal for clinicians.
[61] L. Mayo,et al. Cell type-specific expression of the IkappaB kinases determines the significance of phosphatidylinositol 3-kinase/Akt signaling to NF-kappa B activation. , 2004, The Journal of biological chemistry.
[62] M. Freeman,et al. Cholesterol and prostate cancer , 2004, Journal of cellular biochemistry.
[63] Z. Werb,et al. How matrix metalloproteinases regulate cell behavior. , 2001, Annual review of cell and developmental biology.
[64] A. Zlotnik,et al. The biology of chemokines and their receptors. , 2000, Annual review of immunology.
[65] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.